Macerogen expands its operations in Milan (2021)

investment overview

Investor company description

Macrogen Inc. is a world leader in DNA sequencing, genome analysis and biochips, working closely with over 18,000 researchers in 153 countries. It has several subsidiaries and sequencing facilities in the Netherlands, the United States, Japan, Spain and Singapore.

Macrogen Europe B.V., based in the Netherlands, is one of the subsidiaries of the parent company Macrogen Inc. and provides DNA sequencing and analysis services for Europe and Africa. It works in partnership with various health services, educational and research institutions to assist their research and development activities.

Investment description

In 2021 Macrogen opened a new office and laboratory space in the UniMi Foundation, the incubation and technology transfer center of the University of Milano. The “Invest in Italy” team, composed by the Italian Trade Agency, its office in Seoul and Invitalia, in collaboration with the City of Milano’s investment promotion agency Milano&Partners, supported the company throughout the investment project evaluation with dedicated site visits to Milano’s main scientific parks and other administrative information on the hiring of local young talents.

By choosing Milan from a shortlist of several European locations, the company decided to bet on the growing demand for genomics services coming from Italian customers and Italy’s willingness to gain a leading position in this field.



Accompanying facilities required:

- Support for location scouting

- Market studies for business location

- Support for site visit


Press Release

Macrogen Europe opens Milan Genome Center

website icon